SG&A at other companies
Other financials
Where this comes from
Reported directly by GE HealthCare Technologies in its filing.
Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.
The official record: GE HealthCare Technologies’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about GE HealthCare Technologies's sg&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is GE HealthCare Technologies's SG&A?
- GE HealthCare Technologies (GEHC) reported SG&A of $1.12B in Q1 2026.
- How has GE HealthCare Technologies's SG&A changed year-over-year?
- GE HealthCare Technologies's SG&A increased by 7.4% year-over-year, from $1.04B to $1.12B.
- What is the long-term trend for GE HealthCare Technologies's SG&A?
- Over 4 years (2021 to 2025), GE HealthCare Technologies's SG&A has grown at a 4.4% compound annual growth rate (CAGR), from $3.56B to $4.23B.
- What does SG&A mean?
- Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.